Granted Patent
B2
US 11,046,782 · App. 16/089,498 · Granted Jun 29, 2021
Methods for treatment and diagnosis of cancer by targeting glycoprotein A repetitions predominant (GARP) and for providing effective immunotherapy alone or in combination
Assignee:
MUSC FOUNDATION FOR RESEARCH DEVELOPMENT
C07K16/34A61K9/00A61K9/0019A61K31/675A61K31/7076A61K39/39558A61K45/06A61P35/00C07K16/28C07K16/2827C07K16/2866C07K16/30C07K16/3015C07K16/3046A61K2039/505C07K2317/33C07K2317/76
View Patent ↗
Loading inventors, assignments & file history…
Abstract
Isolated or recombinant monoclonal antibodies that bind to GARP are provided. In some cases, antibodies of the embodiments can be used for the detection, diagnosis and/or therapeutic treatment of human diseases, such as cancer. Further provided herein are methods and compositions for treating cancer in an individual comprising administering to the individual an effective amount of an anti-platelet agent and a T cell therapy.
Claims (2)
1. A recombinant polypeptide comprising an antibody VH domain comprising CDRs 1-3 of the VH domain of 4d3 (SEQ ID NOs: 1, 2, and 3).
2. A recombinant polypeptide comprising an antibody VL domain comprising CDRs 1-3 of the VL domain of 4d3 (SEQ ID NOs: 5, 6, and 7).
Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST
Recorded Nov 13, 2018
From: LI, ZIHAI
To: MEDICAL UNIVERSITY OF SOUTH CAROLINA
Reel/Frame 047491/0307 →
ASSIGNMENT OF ASSIGNOR'S INTEREST
Recorded Nov 13, 2018
From: MEDICAL UNIVERSITY OF SOUTH CAROLINA
To: MUSC FOUNDATION FOR RESEARCH DEVELOPMENT
Reel/Frame 047491/0376 →
Continuity (3)
Provisional Application
62315069
· Mar 30, 2016
Provisional Application
62315121
· Mar 30, 2016
Cited By (2)